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Abstract: Iron oxide nanoparticles are the basic components of the most promising magneto-responsive
systems for nanomedicine, ranging from drug delivery and imaging to hyperthermia cancer
treatment, as well as to rapid point-of-care diagnostic systems with magnetic nanoparticles.
Advanced synthesis procedures of single- and multi-core iron-oxide nanoparticles with high
magnetic moment and well-defined size and shape, being designed to simultaneously fulfill
multiple biomedical functionalities, have been thoroughly evaluated. The review summarizes
recent results in manufacturing novel magnetic nanoparticle systems, as well as the use of proper
characterization methods that are relevant to the magneto-responsive nature, size range, surface
chemistry, structuring behavior, and exploitation conditions of magnetic nanosystems. These refer to
particle size, size distribution and aggregation characteristics, zeta potential/surface charge, surface
coating, functionalization and catalytic activity, morphology (shape, surface area, surface topology,
crystallinity), solubility and stability (e.g., solubility in biological fluids, stability on storage), as well
as to DC and AC magnetic properties, particle agglomerates formation, and flow behavior under
applied magnetic field (magnetorheology).
Keywords: magnetic nanoparticle systems; bio-ferrofluids; nanomedicine; single core; multi-core;
synthesis; functional coating; physical-chemical properties; structural characterization; magnetorheology
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1. Magnetism at Nanoscale and Bio-Ferrofluids—A Brief Introduction
Magnetic nanoparticle systems that are relevant for nanomedicine applications [1,2], such as
biomedical imaging, magnetically targeted drug delivery, magneto-mechanical actuation of cell surface
receptors, magnetic hyperthermia, triggered drug release, and biomarker/cell separation, have some
particular features concerning composition, size, morphology, structure, and magnetic behavior,
which highly motivated the synthesis, characterization, and post-synthesis application-specific
modification of magnetic iron oxide and substituted ferrite nanoparticles [3–10]. These multi-functional
magnetoresponsive particles are highly promising in imaging and treating a lesion, simultaneously
providing a theranostic approach [11–13]. Microscopic phenomena that are associated with the surface
coordination environment, such as canted surface spins, intra- and interparticle interactions (dipolar
or exchange, involving surface spins among different particles), and even increased surface anisotropy,
which are relevant in improving magnetic field controlled driving and heating, as well as magnetic
resonance imaging (MRI) detection, may affect the magnetic behavior of magnetic nanoparticle
systems [14,15]. In the case ferrofluids designed for biomedical applications, the magnetic particles
dispersed in aqueous carrier involve both single-core and multi-core iron oxide (mainly magnetite and
maghemite) nanoparticles (IONPs), consequently bio-ferrofluids [16] widely extend the conventional
domain of ferrofluids referring only to single core high colloidal stability magnetic nanofluids [17,18].
The interaction of a magnetic nanoparticle (MNP) with an external magnetic field [10] is governed
by minimization of the dipole-field interaction energy achieved by the orientation of the particle’s
magnetic moment parallel to the applied magnetic field [3] and, in case of a non-uniform field,
the interaction involves the translation of the particle in the direction of the field gradient, i.e.,
magnetophoresis [19]. The rotation of the magnetic moment of a particle that is suspended in a liquid
carrier can occur either free with respect to the particle (Néel rotation) or together with the particle
(Brown rotation) [4,20,21]. The orientation of MNP’s magnetic moment in alternating current (AC)
magnetic fields shows hysteresis, except for particular situations. The phenomenon of AC magnetic
hysteresis is the basis of magnetic particle hyperthermia [21,22] and susceptometric granulometry of
single and multicore MNPs [23]. In direct current (DC) magnetic fields, the magnetization of diluted
single core particle dispersions follows the Langevin equation, which gives the theoretical framework
for the magnetogranulometry of single core particles, due to the permanent magnetic moment of
subdomain MNPs [24]. Depending on size, magnetic nanoparticles are subject of various contributions
to their anisotropy energy [25–27], influencing the overall magnetic behaviour of the MNP system.
The main forms of anisotropy specific to magnetic nanoparticles are summarized in what follows:
(a) Magnetocrystalline Anisotropy: this property is related to the crystal symmetry and the arrangement of
atoms in the crystal lattice. Magneto-crystalline anisotropy can show various symmetries, but uniaxial
and cubic forms cover the majority of cases [28,29]. (b) Magnetostatic anisotropy (shape anisotropy):
this contribution is due to the presence of free magnetic poles on the surface creating a magnetic
field inside the system (i.e., demagnetizing field) which is responsible for the magnetostatic energy.
Subsequently, for a particle with finite magnetization and non-spherical shape, the magnetostatic
energy will be larger for some orientations of the magnetic moments than for others. Thus, the shape
determines the magnitude of magnetostatic energy and this type of anisotropy is often called as shape
anisotropy [28,30,31]. (c) Surface anisotropy: Surface anisotropy, which increases with the increase in
surface-to-volume ratio (i.e., a decrease in particle size), gives rise to the lower symmetry of surface
atoms with respect to the atoms located within the particle [26,31]. Surface anisotropy is also strictly
related to the chemical and/or physical interactions between surface atoms and other chemical species.
The coating and functionalization of the nanoparticle surface can induce important modifications in its
magnetic properties, referring to the so-called “magnetic dead layer” due to spin-canting [32–34].
Multicore particles have no permanent magnetic moment, provided that the constituent particles
are small enough, such that the magnetic dipole-dipole interactions are negligible. The induced
(resultant) magnetic moment of multicore particles is parallel to the external magnetic field and it
follows the Langevin equation. The multicore particles show magnetic coercivity and remanence due
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to dipole-dipole interactions if the constituent particles are large, i.e., the anisotropy energy overcomes
the thermal energy. The induced magnetic moment of multicore particles at saturation is the sum
of the constituent particles’ magnetic moments [35]. Many applications of magnetic nanoparticles
and nanocomposites in medicine rely on their ability to be manipulated while using magnetic fields.
This ability depends on the effectiveness of the magnetophoretic force, being determined by the particle
magnetic moment and the field gradient, to fix or to move the particles [19,36,37]. The magnetophoretic
force exerted upon single core superparamagnetic nanoparticles is less effective due to their small
diameter and magnetic moment implicitly, but, in the case of multicore composites, the resultant field
induced magnetic moment is high enough in order to allow magnetic targeting already for moderate
values of field intensity and gradient. Multi-core particles with relatively large overall sizes manifest
strong magnetic response and, also, preserve the superparamagnetic behavior. Indeed, these multicore
composites of sizes well above 20 nm show superparamagnetic properties at room temperature (300 K),
while at very low temperature (~2 K) clusters of similar sizes would exhibit typical ferromagnetic
hysteresis loops [38]. The particles’ magnetic moment is more relevant than mass magnetization in
order to assess the magnetic targeting/fixing applicability of magnetic particles [19,39,40].
In this review, we aim to focus on the latest trends in magnetic nanosystem research for
nanomedicine applications, involving synthesis, structural, colloidal, magnetic and magnetorheological
characterization, as well as demonstrating efficient progress and still existing weaknesses.
2. Designed Synthesis of the Magnetic Core
The preparation of superparamagnetic iron oxide nanoparticles (SPION) dispersions can be approached
from two directions [41]: (i) from heterogeneous phases via dispersion (grinding and dispersing solid
phase) of iron or iron oxides into aqueous solution and (ii) from homogeneous phases via condensation
of precursors from either liquid or gaseous phase [42]. These have recently been called as the top down
(mechanical attrition) and bottom up (chemical synthesis) methods of nanoparticle fabrication [43].
The bottom-up synthesis procedures [43–46], for example the coprecipitation of Fe(II) and
Fe(III) salts, sol-gel processes, polyol methods, sonolysis [45], thermal decomposition, solvothermal
reaction [47], hydrolytic and non-hydrolytic wet chemistry methods [3], liquid phase, polyols,
thermal decomposition, microemulsion, and laser evaporation syntheses, biomineralization, [22],
are considered to be the most effective ways of fabricating SPIONs. In a recent review [9], referring
to the synthesis of shape-controlled magnetic iron oxide nanoparticles, it was emphasized that the
nucleation and growth/agglomeration are the main stages in any colloidal or wet chemistry synthesis
route. If monodisperse nanoparticles are aimed to be synthesized, the stages should be pulled apart
in temperature and time, otherwise the polydisperse system and diverse particle morphology are
obtained. For anisometric nanoparticles, like cubes, rods, disks, flowers, and many others, such as
hollow spheres, worms, stars, or tetrapods, the growth is the crucial step and the specifically adsorbing
ligands are responsible for the final morphology of nanoparticles. Uniform-sized nanoparticles from
3–4 up to 20 nm have been obtained through a seeded growth mechanism. The decomposition of
iron stearate at high temperature in the presence of different surfactants allows to synthetize mixed
crystals of magnetite and maghemite with sizes between 4 and 28 nm [48]. The synthesis parameters
(precursors, additives, and their ratio) and experimental conditions (reaction time, temperature) were
changed, and monodisperse, single core (this term was not used in the paper) crystals with different
classes of size (e.g., 7–8, 10–11 nm) were made.
The thermal decomposition of organic precursors takes place in the presence of surfactant
stabilizers. Nucleation events for the formation of the nanocrystals are controlled and, thus, the size
and the use of surfactants allow for monodispersity. In this process, surfactant stabilized hydrophobic
particles form that needs further treatments to transfer them into aqueous media. The latter can be
achieved by using surfactants (e.g., Na-oleate), forming an oppositely oriented second layer due to
hydrophobic interaction with the alkyl chains of first layer chemisorbed on the surface of IONPs [49].
The long-term stability of aqueous magnetic colloids under the effect of magnetic field in biorelevant
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media has not been evidenced yet [17]. If oleic acid is used in the synthesis, the double bonds of
chemisorbed oleate can be oxidized by strong oxidant (e.g., KMnO4 under acidic or alkaline conditions).
Azelaic acid forms in an oxidization reaction on the IONPs’ surface, and the carboxylated product
has good dispersibility in aqueous media [50]. The surfactants with hydrophobic alkyl chains can be
replaced by hydrophilic molecules having functional groups (e.g., carboxylic acid, phosphonic acid,
aromatic molecules with OH groups in ortho position) that have a higher affinity to ≡Fe-OH sites on
IONPs’ surface in a ligand-exchange process often used lately [51].
While keeping the superparamagnetic behavior, the synthesis of multicore particles proved to be a
promising solution for magnetics based imaging, therapeutics, and sensing to improve the manifold
magnetic response of particles [40,52–56]. Magnetic nanoparticle clusters embedded in a polymer
shell, to sum the magnetic moments of each nanoparticle, were made applying in situ coprecipitation
by using gels as microreactors [57,58], and also by strongly polar solvent induced destabilization
of a ferrofluid [59]. The miniemulsion technique is also well-established to control clusterization
of magnetic nanoparticles [60]. The densely packed magnetic clusters are encapsulated in a polymer
shell [61,62]. High magnetization spherical particles in thermoresponsive polymer shell were produced in
a ferrofluid miniemulsion procedure [63,64]. Hydrophobic oleic acid coated SPIONs of a light organic
carrier (hexane, toluene, tetrahydrofurane) based ferrofluid may also be incorporated into chitosan
amphiphile nanoparticles by the ultrasonic emulsification procedure and evaporation of the volatile
carrier [65]. The magnetic behavior of nanoparticle assemblies is strongly dependent on interparticle
interactions, in particular on dipole-dipole interactions and exchange coupling between surface atoms,
with the size and molecular coating of magnetic nanoparticles controlling the resulting arrangements [66].
Various magnetoresponsive nanocomposite particles with adjustable properties (e.g., size,
magnetic moment, surface charge, morphology, shell thickness) were synthesized during the last
period of time. Figure 1 collects some of these multi-core particles to illustrate the results in the design
and manufacture of these magnetic carriers that have to respond to requirements of colloidal stability
in aqueous dispersion media, as well as of achievable values of magnetic field strength and gradient.
It is essential to ensure high values of the magnetic moment, which is one of the most important
requirements, for successful applications in biomedicine of functionalized nanocomposite carriers, in
particular in magnetic targeting [19,67,68]. In this respect there are different approaches to distribute a
certain amount of magnetic nanoparticles, such as onto the surface of a non-magnetic core [69], or on
layered silicate (e.g., montmorillonite) support with high surface area [70], enclosed in a thin vesicle
bilayer [71], or close packed to form a magnetic core, the magnetic core-organic shell nanocomposites
being favored by their high magnetic response [72]. MNP clusters that are prepared from aqueous [73]
and organic [74] ferrofluids can be used to obtain magnetoliposomes [75] with high magnetic response
and MRI contrast for in vivo drug and gene delivery into cancer cells. IONPs and anticancer drugs
were enclosed into nanocapsules that were designed to be responsive to remote radio frequency (RF)
field for ON–OFF switchable drug release [76]. Ferrofluids, as primary materials, provide hydrophobic
IONPs to be encapsulated together with camptothecin anticancer drug into PPO (polypropylene oxide)
block of Pluronic vesicles. The developed continuous manufacturing procedure is scalable and it
provides multi-core theranostic drug delivery vehicles [77].
The usually spherical morphology resulting in oil (ferrofluid)-in-water miniemulsion procedure
is modified when the hydrophobic oleic acid coating of MNPs is incomplete and the hydrophobic
character of particles significantly reduces. As a consequence, the MNPs accumulate at the ferrofluid
drop-water interface, resulting in strongly non-spherical shape nanocomposite particles [39]. Magnetic
field guided evaporation of ferrofluid droplets [78,79], making use of specific Rosensweig instabilities
and tuning the concentration of ferrofluid, allows for preparing various shaped nanocomposites
(so-called “supraparticles”) and also preserving superparamagnetic behavior. The high evaporation
rate organic ferrofluids having oleic acid monolayer coated magnetite NPs were used to fabricate
magnetoactive fibrous nanocomposites and multi-responsive co-networks [80,81], which exhibit promising
characteristics for magnetothermally or pH triggered drug delivery.
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More recently nanoflower type composites came into the play [82], whose formation is due to
exchange interactions between the cores favoring cooperative behavior and a crystal continuity at
the core interfaces. The magnetic nanoflowers manifest enhanced susceptibility while maintaining
superparamagnetic behavior; their structure (e.g., the contact between cores within a particle, having
a strong impact on the collective magnetic properties [83]) critically depends on the synthesis
process. Two routes of the latter can be differentiated: the polyol method and thermal decomposition.
For example, the 1:2 mixture of Fe(II) and Fe(III) salts was hydrolyzed in organic solvent mixture
(diethylene glycol and N-methyldiethanolamine) at high temperature; the clustering and coalescence
of seeds took place during the longer period [84]. In this single step process, a big mixture of
coalesced flower-like maghemite nanoparticles formed, which was fractionated by increasing salt
content of aqueous system at low pH, taking advantage of electrostatic colloidal stability. Figure 2
shows the nanoflowers formed in the one pot synthesis and two fractions selected as examples to
distinguish the single and multicore IONPs. Different routes based on the partial oxidation of Fe(OH)2,
polyol-mediated synthesis, or the reduction of iron acetylacetonate were used to obtain multicore
iron oxide nanoflowers in the size range 25–100 nm [82]. The nanoparticles were either stabilized
with well-known agents, such as dextran and citric acid, or, as an alternative, IONPs were embedded
in polystyrene to ensure long-term colloidal stability. The first steps toward the standardization of
the synthesis and characterization of nanoflowers have been attempted. By now, better quality of
magnetite nanoflowers can be also synthesized by thermal decomposition in organic media [25].
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oxide (right) ([77]). (2) thermal decomposition: left—TEM images of polymer encapsulated colloidal 
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gray ring is caused by the polymer shell (lower electron density) of around 20 nm thickness ([59]); 
right—High Resolution TEM of multi-core MNP showing the continuity of the crystal lattice at the 
Figure 1. Magnetic multi-core particles obtained by different synthesis procedures: (1) encapsulation of
magnetic nanoparticles (MNPs) into liposomes, polymersome: left—TEM (b) and cryo-TEM (c) micrographs
of Ultra Magnetic Liposomes (UMLs) prepared by reverse phase evaporation process (REV) process.
MNPs are trapped inside unilamellar vesicles (c) and dipole−dipole interaction can occur as exemplified
by magnification (b) ([73]); right—Cryo-TEM image showing iron oxide nanoparticles incorporated in
the polymersome membrane with 4.1% iron oxide (left), and 17.4% iron oxide (right) ([77]). (2) thermal
decomposition: left—TEM images of polymer encapsulated colloidal ordered assemblies (polymer-COA)
at higher (A) and lower (B) resolution. The dark pattern (A) results from the ordering of the closed
packed assemblies within the nanobeads, while the brighter gray ring is caused by the polymer shell
(lower electron density) of around 20 nm thickness ([59]); right—High Resolution TEM of multi-core
MNP showing the continuity of the crystal lattice at the grain interfaces. The Fourier transform of this
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high resolution image (see inset) shows the monocrystalline fcc structure of the multi-core nanoparticles,
oriented along the [001] zone axis ([84]). (3) miniemulsion: left—TEM images of magnetic
microgel with magnetite nanoparticles cluster as a core coated with two layers of cross linked
polymer shells poly-N-isopropylacrylamide-polyacrylic acid ([63]); center—TEM image of magnetic
clusters encapsulated in a copolymer hydrogel poly(N-isopropylacrylamide-acrylic acid). Scale bar:
100 nm ([62]); right—TEM image of cross section of superparamagnetic microparticles produced with
ferrofluid nanoparticle concentrations of 1 g/L using oil-in water emulsion-templated assembly ([39]).
Reprinted with permission from Reference [41].
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3. Magnetic Nanoparticles in Aqueous Carrier
3.1. Ferrofluids vs. Bioferrofluids
The main distinctive feature of ferrofluids among the larger class of magnetic colloids is their
long-term colloidal stability, even in strong and non-uniform magnetic fields specific to most of
applications. In the carrier liquid, the overall particle interaction potential should be repulsive, i.e.,
the attractive van der Waals and magnetic forces have to be balanced by Coulombic, steric or other
interactions, in order to ee particles apart from eac other [17]. The stabilization of magnetic
fluids impedin aggregate formation is more challenging for aqueous than for organic carri rs.
The necessary increase of magnetic particle concentration also involves a increase of the hydrodynamic
volume fraction of surface c rticles determined by the stabilization procedur , electrostatic
or electro-steric, which differentiate water-based ferrofluids, to attain high values of saturation
magnetization. The steric st ili i l r ( sually a chemisorbed primary and a physisorbed
secondary layer of surfactant molecules) has a uch greater thickness than the electrostatic one,
therefore the hydrodynamic volume fraction at the sa e agnetic volume fraction is much higher
(approx. 7–8 times) for electro-steric (e.g., oleic acid double layer) than for electrostatic stabilized
aqueous ferrofluids [85]. The significantly reduced interparticle distance produces colloidal stability
issues that involve nanoparticle size and magnetic moment, dipolar interactions, excess surfactant, and
agglomerate formation. Ferrofluids designed for biomedical applications—bio-ferrofluids [16]—involve
beside single-core particles, a large fraction of multi-core magnetic nanoparticles coated with single or
multiple biocompatible surface layers [41], to be discussed in what follows.
3.2. Surface Coating of Magnetic Cores
The surface coating of magnetic iron oxide nanoparticles (IONPs) is inevitable to protect iron
leaching, to optimize long term and in-use colloidal stability, to ensure biocompatibility, and to provide
specific sites to graft biological functions as well. Therefore, the coating of magnetic nanoparticles
should be carefully designed.
The different synthesis methods commonly produce IONP particles that are coated with a protective
shell. The preparation of naked IONPs is relatively rare in the literature, probably for the reason that
the surface properties of naked IONPs definitely depend on pH and nanoparticles strongly aggregate at
neutral pHs, as discussed above [86,87]. The colloidal stability of IONPs under biorelevant conditions,
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e.g., in blood, at pH~7.4 in physiological salts and protein concentration is the minimum requirement
for biomedical applications [71,88]. Therefore, the aggregation of IONPs has to be prevented by
protective coating, which can be created either during or after their synthesis. In the literature, in situ
coating, post-synthesis adsorption, or post-synthesis grafting are distinguished [68]. In the latter, the
functional groups of brush-like polymer chains are anchored to the IONP’s surface. Covalently bound
molecules can more improve colloidal stability than adsorbed ones, as demonstrated, for example, in the
work of Rinaldi and co-authors [89,90]. However, a great disadvantage of the former is the expensive
purification process to remove impurities from organic synthesis to reduce the chemical hazard of
the formulation. The multipoint adsorption of polyelectrolytes, especially natural polysaccharides,
such as chondroitin-sulfate-A (CSA) bound chemically to ≡Fe-OH surface sites of IONPs, is suitable
for fabricating biocompatible magnetic fluid (MF) and magnetoresponsive nanocomposites [91–94].
Biopolymer coated magnetite nanoparticles fulfill all assumption of biomedical application, as shown
in Figure 3.
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VS P-C184 product) in [45,95,96] or of the ulti-core sa ples in [97]). o ever, the citrated I Ps
coagulate, even at low salt concentration and, moreover, their iron leaching is very high because
citric acid has a reducing effect, and it for s complexes with the surface Fe ions [98]; the dissolved
iron ions may cause oxidative stress besides the danger of particle aggregation in vivo. Amstad and
co orkers [71] reported a similar iron dissolution effect of catechol derivatives (e.g., mimosine) grafted
to Fe3O4 surfaces, causing the gradual dissolution of Fe3O4 nanoparticles through complexation.
The other key point is the formation of protein corona of MNPs in biological fluids [99]. Up to now,
the coating IONPs with hydrophilic agents is the most widely accepted method for overcoming this
proble . Polyethylene oxides or glycols (PEG) and carbohydrates like dextran [3,71] or carbohydrate
derivatives (such as mannose, ribose, and rhamnose) [84,100] are the most common of many coating
agents, which are chemically bound to the ≡Fe-OH surface sites or by multiple H-bonds, and make
IONPs super hydrophilic, inhibiting the adsorption of proteins. However, the formation of protein
corona on MNPs covered with dextran and its derivatives has been perceived [101]. Other types of PEG
coating on IONPs (grafting with poly(ethylene glycol)-silane [90] or in situ forming in the poly(ethylene
glycol) and poly(ethylene imine) mixture [102]), i.e., the PEGylation can generally improve the drug
delivery, enhance the drug accumulation, and might improve the blood-brain barrier transport of
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IONPs [68]. A new design of PEGylated coating (P(PEGMA-co-AA)@MNPs) provides a non-fouling
outer surface that helps the nanoparticles to remain “invisible” for the phagocytic mechanisms, while
its free carboxylate moieties can be exploited for grafting specific biologically active molecules or
proteins for theranostic applications [103].
Using the synthesis procedure of carboxylic (lauric, myristic or oleic) acid stabilized aqueous
ferrofluids [49,104], bovine serum albumin (BSA) coating was applied to rise the colloidal
stability of lauric acid-coated IONPs in biological media [105]. The coating greatly reduced the
toxicity of nanoparticles and enhanced therapeutic potential of mitoxantrone drug-loaded system.
Further cross-linking of BSA coating was performed in order to improve colloidal stability [106], and
monoclonal antibodies were covalently bound to BSA coated IONPs promising MRI contrast agents
for glioma visualization in brain.
Nanoparticles interact with biological entities in a biological environment, and nano-bio interfaces
form [107]. Only the particle surface can be modified to improve in vivo biocompatibility of
nanoparticles. Seeing this issue, the size, the sign, and magnitude of surface charge (as manifested in
the measurable zeta potential) and dispersibility in aqueous media (hydrophilic/hydrophobic feature)
are the main options for change. Experiments have already shown that positively charged particles are
probably more toxic than the larger hydrophobic ones clearing rapidly in the reticuloendothelial (RES)
system. In biological systems, medium-sized particles with a neutral or weakly negatively charged
surface generally tend to promote enhanced permeation and retention (EPR) [107].
A new generation of coating agents P(PEGMA-co-AA), which combine charged functional groups
(i.e., carboxyl groups that are capable of anchoring both nanoparticles and bioactive molecules) and
superhydrophilic uncharged segments (i.e., PEG chains in comb-like arrangement) has been reported
last year [103]. In a post-coating process, these multifunctional molecules are able to spontaneously
bind to MNPs’ surface sites ≡Fe-OH; stabilize the particles electrostatically via the carboxylate moieties
and sterically via the PEG moieties; provide high protein repellency via the structured PEG layer;
and, anchor bioactive molecules via chemical bond formation with the free carboxylate groups.
The electrosteric (i.e., combined electrostatic and steric) stabilization is efficient down to pH 4 and it
tolerates saline media.
In biomedical applications, an optimized coating on SPION surface is required, via which IONPs
can interact with different biological entities (proteins, cell membranes, etc.). Only the coating on the
engineered NPs can be freely varied at the nanobio interface. The core of nanoparticles has almost all
of the desired properties, such as chemical composition, shape and curvature, porosity and surface
crystallinity, heterogeneity, and roughness, as listed by Nel and coworkers [107]. The coating layer
of core-shell nanosystems provides optimal hydrophobicity/hydrophilicity in a given medium and
active sites for anchoring biofunctions. In the same article, the other quantifiable properties of NPs’
interactions (dissolution, hydration, zeta potential, aggregation/dispersion, etc.), which are crucially
influenced by the ionic strength, pH, temperature, and the presence of large organic molecules (e.g.,
proteins), or specifically adsorbing molecules or ions (e.g., detergents generally or phosphate ions)
of the suspending media, are separately discussed. The composition and structure of interfacial
layer on coated NPs, as well as its changes on the nanoscale, definitely affect the microscale and
more the macroscale behavior of engineered nanoparticles. The quality of coating interrelates with
colloidal stability under biorelevant conditions, as described in [108]. Sedimentation, freezing, and
hemocompatibility tests (smears) are recommended for the qualification of good and bad SPION
manufacturing for intravenous administration. Besides the colloidal stability of nanosystems, coatings
also largely affect the functionality and biological fate of IONPs. Several different functions of NPs’
coating can be identified, namely: (i) colloidal stabilization under physiological conditions (protecting
against aggregation at biological pHs and salty medium), (ii) inhibiting the corrosion and oxidation of
magnetic core (passivation reducing the iron leakage), (iii) hindering non-specific protein adsorption
in biological milieu, (iv) providing reactive groups for anchoring drugs and targeting molecules, and
(v) controlling nano-bio interfacial interactions (bio/hemocompatibility, reticuloendothelial system
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(RES) uptake, blood circulation time, IONP’s internalization efficiency, toxicity, targeting efficiency,
in vivo fate, etc., as discussed in detail [3,41,68,71,107]). These functions of coating largely overlap
with the general concerns of EMA (European Medicines Agency) [109] that should be considered in
the development of nanomedicine products.
3.3. Stabilization Mechanisms
The dispersed nanoparticles move freely (thermal motion) in the carrier medium. The colloidal
stability of dispersion is the question, whether nanoparticles can retain their separateness during
collisions; i.e., whether the particle-particle interactions that are controlled by the frequency and
efficiency of collision result in aggregate or not. The latter depends on the extent of attractive and
repulsive contributions to the total interaction. The classical DLVO theory of colloidal stability describes
the attractive (van der Waals) and repulsive (electrostatic) forces. In addition to these, the hydration,
the hydrophobic interactions, and the steric hindrance should be also assessed [110,111]. In the case of
magnetic particles, besides the short range exchange interaction especially relevant to formation of
multi-core particles, such as nanoflowers [83], the magnetic dipole attraction having a fundamental
effect on the collective magnetic properties must also be taken into account [112] to obtain reasonable
theoretical stability predictions [90]. In these papers particle aggregation is used as a generic term for
coagulation and flocculation independently of the inner structure of aggregates and the reversibility
of their formation. Another term, agglomeration, has appeared in the relevant literature, with the
same or different meanings as aggregation. Gutiérrez and coworkers [83] reviewed the aggregation of
magnetic iron oxide colloids and definitely stated that “nanoparticles tend to form assemblies, either
aggregates, if the union is permanent, or agglomerates, if it is reversible”, recalling a bit industrial
terminology or that used in nanotechnology nowadays. However, there are certain inconsistencies
with the classical colloid nomenclature (e.g., in refs. [110,111]), where aggregation involves coagulation
and flocculation giving rise to compact and loose structures, respectively. Their reversibility depends
on the magnitude of mechanical force against they should exist. For example, coagulum, the aggregate
that forms in the coagulation process, is irreversible against thermal motion; however, it disintegrates
when subjected to stronger shaking, stirring, or even mild ultrasonication, and, after this, coagulation
restarts at rest, so its formation is reversible [111].
In [113], it was emphasized that nanomaterials should be characterized in the relevant medium,
and not simply in water, especially in what concerns aggregation (agglomeration) processes. Referring
to coagulation kinetics, IONPs’ colloidal stability should be acceptable under biorelevant conditions, i.e.,
at biological pH values, in the presence of salt and proteins, and also in cell culture media. In classical
colloid science, coagulation kinetics can correctly characterize colloidal stability, also allowing for
predicting the stability of SPIONs’ products both on storage and in use. However, the measurements
require advanced instrumentation and a lot of time, thus a simpler method would be needed to test
SPION preparations [108]. Particle aggregation tests (size evolution, filtration, sedimentation, etc.)
under arbitrary conditions are often used [71]. Coagulation kinetics is useful for testing the salt tolerance
of IONPs and predicting their resistance against aggregation under physiological condition [87].
A straightforward route of physicochemical (iron dissolution) and colloidal (pH-dependent charging
and particle size, salt tolerance from coagulation kinetics) measurements was suggested for assessing
the eligibility of IONPs for in vitro and in vivo tests [98].
4. Physical-Chemical Characterization
4.1. Chemical Composition of Magnetic Nanoparticles
X-ray Photoelectron Spectroscopy (XPS) is a very sensitive surface analysis method for the
materials chemical composition. The method allows for the determination of the atomic concentrations,
the chemical state of the emitting atoms (oxidation degree, valence states, chemical ligands, etc.).
This information results from the areas delimited by the photoelectron peaks and from the chemical
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shifts of the peaks with respect to the elemental state, as induced by the chemical surrounding of
the atoms. The electrostatic interaction between the nucleus and the electrons determine the core
binding energies of the electrons. The electrostatic shielding of the nuclear charge from all other
electrons in the atom reduces this interaction. The removal or addition of electronic charge will alter
the shielding: withdrawal of valence electron charge (oxidation) increase in binding energy; addition
of valence electron charge decrease in binding energy. Chemical changes can be identified in the
photoelectron spectra.
In the case of magnetic nanoparticles, surface properties strongly influence their magnetic
performance and their behavior in biological media. The core-shell type magnetic nanoparticle
systems consist of the magnetic core and a shell around the core, usually a biocompatible polymer
and additionally molecules fulfilling the roles of anchors, spacers, and various functionalities. XPS
provides information regarding the chemical composition of the coating layers and, on the other hand,
allow for determining the oxidation state of the metal in the magnetic core [63,114–117]. XPS allows for
determining the oxidation states of iron and to quantify Fe2+ and Fe3+ ions in iron oxide nanoparticles.
These oxidation states of iron can be determined by Fe2p spectrum employing chemical shift and
multiplet splitting and the characteristic satellites [85,118–122].
The organic coating layers of magnetic nanoparticles have major importance for biomedical
applications of these nanomaterials. Coating layers ensures the chemical and colloidal stability of
magnetic nanoparticles and allow for further functionalization [122–124]. Surface functionalization of
magnetic nanoparticles for biomedical applications remains a major challenge. XPS is one of the most
appropriate methods for the analysis of the functionalized organic coating of magnetic nanoparticles.
The optimization of the required properties for applications requires understanding the nature of the
interface between the magnetic core and the shell and the influence of the surface complex formation
on the nanoparticle’s magnetic properties.
Mazur and coworkers reported a good strategy for surface functionalization of magnetic
nanoparticles allowing for the simultaneous attachment of dopamine anchors bearing azide, maleimide,
and alkyne terminal groups [125] (Figure 4). This functionalization strategy of nanoparticles by using
dopamine derivatives shells has the advantage that, besides the protection of the iron oxide core
offering the possibility to integrate in a one-step reaction several reactive sites onto the nanoparticles,
making these functionalized nanoparticles very promising for biomedical applications.
XPS allows for a detailed analysis of surface chemical composition of iron oxide nanoparticles
before and after functionalization with dopamine derivatives (Figures 5 and 6).
The ratio Fe/O = 0.73 was calculated from XPS spectra, which is in-between that of Fe3O4 (0.75)
and Fe2O3 (0.66). This fact and the peak position and satellite peaks in Fe2p spectrum indicate
that the magnetic core contains Fe3O4 and Fe2O3. The presence of dopamine derivatives shells on
the magnetic core was evidenced in the high resolution spectra of N1s and C1s core level spectra.
The deconvoluted N1s spectra of Fe3O4 that were coated with dopamine derivatives (Figure 6) evidence
the characteristic groups of the organic shells. The calculated atomic ratio C/N is a good estimation for
the success of the organic coating on magnetic nanoparticles. The XPS spectra and the calculated atomic
concentrations for the elements C, O, N, and Fe evidence the coating of the magnetic nanoparticles
with dopamine derivatives.
The coating layers largely influence the colloidal stability of magnetic nanoparticles under
physiological conditions [3,68,71,107]. The protein corona’s effect differs significantly, depending on
the surface chemistry of the nanoparticles. The surface chemistry strongly influences the formation of
protein corona and the cellular uptake of the nanoparticles. Differences in protein corona formation
have been observed for magnetic nanoparticles coated by different organic layers [126,127]. Szekeres et
al. undertook a comparative study of the effect of protein corona formation on the colloidal stability of
magnetic nanoparticles coated by polyelectrolyte shells, citrate (CA@MNP), and poly(acrylic-co-maleic
acid) (PAM@MNP) [128]. PAM coating of MNP ensures a better stability at higher human plasma
concentrations as compared with CA coated MNP. XPS determined the chemical composition (atomic
Magnetochemistry 2020, 6, 2 11 of 36
concentrations), as well as the chemical state of the atoms at the surface magnetic nanoparticles
CA@MNP and PAM@MNP. The relevant differences between the nanoparticles CA@MNP and
PAM@MNP can be observed in the XPS spectra for C1s core levels (Figure 7). Both spectra of C1s
contain the carboxylic groups and in the case of CA@MNP the C-OH group appears according to the
characteristic coating shells.
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provides excellent stability [108]. However, outstanding salt tolerance can be achieved through
hydrophilic polymer coating, such as dextran, a polysaccharide, which is used commonly in aqueous
magnetic fluids [68,95,129]. Silica materials [130], organic molecules (e.g., carboxylates, phosphates,
phosphonate, sulfates, amines, alcohols, thiols, etc. [68,88,95]) are often applied as coating agents to
ensure colloidal stability. The functional groups of organic agents are mostly chemically bound to
the reactive (both charged and uncharged) sites on IONPs’ surface. For example, citrate through its
OH and COOH groups are chemically linked to ≡Fe-OH sites in the citrated-electrostatic stabilized-
magnetic fluids [98] or dopamine by two phenolic OH groups in the favored core-shell products [71,95]).
The effect of surface coverage is hardly studied. IONP dispersions coagulate at a pH below PZC (point
of zero charge), if polyacids, such as polyacrylic acid, are present in trace amounts, while their higher
loading covers completely IONPs’ surface and improves the stability and salt tolerance of colloidal iron
oxide dispersions [68,131]. Macromolecules adsorb at multiple sites of surface, the so-called multi-site
bonding makes the coating layer resistant against dilution and the purification of equilibrium medium
easy [110,132].
To illustrate the significance of the stabilization mechanism applied-electrostatic or electrosteric-the
zeta potentials and hydrodynamic sizes were measured for citrate and oleate stabilized aqueous
ferrofluid samples and are given in Figure 8 to show the characteristic pH-dependence due to the
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The MF/CA sample loses colloidal stability below pH6 (Figure 8a) due to the difference in the
charged state of citrated and oleic acid double layer coated MNPs, while the MF/OA ferrofluid
below pH5 (Figure 8). This behavior is explained by the different dissociability values for citric acid
(pKa1 = 3.13, pKa2 = 4.76, and pKa3 = 6.40) and oleic acid (pKa = 5.02). Additionally, from Figure 8a,b,
it follows that over a broad range of pH values, where both type of samples are stable, the citrate
covered particles have a smaller Z-average diameter than the oleic acid covered nanoparticles.
4.3. Magnetic Properties
The magnetic field dependence of the magnetization, i.e., the magnetization curve, provides
information regarding the magnetic properties of single and multicore magnetic nanoparticle systems.
The magnetization of single and multicore magnetic nanoparticle systems is conditioned by the
magnetic relaxation processes that are specific to the composition, dimension, morphology, etc., as well
as external conditions, like temperature.
The direct current (DC) magnetometry is the most frequently used magnetic characterization
method. The DC magnetization can be measured by means of vibrating sample magnetometry (VSM),
alternative gradient magnetometry (AGM), and superconducting quantum interference device (SQUID).
Important characteristics of the sample can be directly obtained from the magnetization curve: initial
susceptibility (χi), saturation magnetization (Ms), coercive field (Hc), and remanent magnetization (Mr).
In the case of superparamagnetic systems, the DC first magnetization curve can be used to determine
the statistic of the nanoparticles’ magnetic diameter by means of magnetogranulometry [133]. Figure 9
presents the DC magnetization curve and the theoretical fit [24] for a sample of dried magnetic microgels
with magnetite nanoparticles [35]. The inset of Figure 9 shows the nanoparticle size distributions that
were obtained from magnetogranulometry and TEM.
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Several groups recently developed AC magnetometry [134,135] with the aim of determining the
hysteresis loss in magnetic nanoparticles used in magnetic hyperthermia applications. The method is
generally useful for characterizing the magnetic dynamic response of single and multicore magnetic
nanoparticle systems at low and high frequencies in the range 1 kHz–1 MHz. Figure 10 presents
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the frequency dependent dynamic response for 9 nm (Sample I—Figure 10a) and 21 nm (Sample
II—Figure 10b) iron oxide nanoparticles, respectively [134]. The hysteretic loss is significantly larger in
the bigger diameter nanoparticle sample.
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AC susceptometry measures the frequency dependence of the real and imaginary part of the
magnetic susceptibility [133]. AC susceptometry is sensitive to the colloidal state of the magnetic
nanoparticle dispersion, apart from being useful for the characterization of the relaxation mechanisms
of the magnetic moment at the nanoscale. Figure 11a presents the frequency dependence of the
normalized components of the complex susceptibility of a ferrofluid sample at different moments
of the phase separation process [136]. Figure 11b shows the phase separation in a 10 mT DC field.
Thus, it is shown the nontrivial influence of the magnetically induced phase separation on the complex
susceptibility spectrum of ferrofluids.
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ZFC-FC measurements can characterize the superparamagnetic state of magnetic nanoparticles
either isolated or in multi core environments [133]. The sample is cooled down from the
superparamagnetic state to the lowest achievable temperature and the magnetization is measured
while heating up the sample in an ~100 Oe applied field (ZFC) and afterwards the magnetization is
measured while cooling the sample down again under the same applied field (FC).
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4.4. Structural Characterization of Magnetic Colloids by Scattering Techniques
4.4.1. Neutron and X-ray Scattering
Scattering methods (neutron or X-rays) are powerful techniques for structural characterization at
the nanoscale and contribute much to the development of nanomaterials. It is well known that the
properties of the systems containing nanoparticles, such as liquid dispersions, are strongly related to
the shape and size of the nanoparticle. Thus, systematic studies of these structural and morphological
characteristics are required. Nowadays, small-angle scattering (SAS) and reflectometry are widely
applied for nanostructure characterization in bulk and at interfaces, respectively. The main difference
between neutron and X-ray scattering is the sensitivity to various chemical elements and their spatial
distributions. The sensitivity to magnetic structures in the objects under study is an additional
possibility for neutron scattering.
In the course of the SAS experiment, the widening of the neutron or X-ray beam that passed
through the sample is analyzed in terms of the differential scattering cross-section per sample volume
as a function of scattering vector module. Such dependence is quite sensitive to structural features
of the studied systems at the scale interval of 1–300 nm [137], which makes SAS an ideal tool for the
structural characterization of ferrofluids [138–140], since the size of particles in them are mostly in this
dimensional range. Specific techniques, such as contrast variation and scattering of polarized neutrons,
are used in small-angle neutron scattering investigations. From small-angle neutron (SANS) and X-ray
(SAXS) scattering, it is possible to derive information regarding particle structure (size, polydispersity,
stabilizing shell thickness, composition of particle’s core and shell, solvent rate penetration in surfactant
layer, structure of possible micelles in solutions), magnetic structure (magnetic size and composition),
particle interaction (interparticle potential, magnetic moment correlation, phase separation), and cluster
formation (developed aggregation and chain formation). The main task of the SAS experiment is to
find out the distribution of scattering length density (SLD), which is defined as a specific sum of the
coherent scattering lengths of atoms in a sufficiently small volume and it is usually represented in
units of 1010 cm−2.
Studying the reflectivity of the radiation (neutrons or X-rays) from planar surfaces is the basic
idea of the reflectometry method [141]. The classical analysis of specular reflectivity allows one to
determine an SLD profile (thickness, density, and roughness of each layer at interfaces) for the studied
object in a direction perpendicular to the interface for a thickness up to hundreds nm with a resolution
of 1 nm. The analysis of off-specular (diffuse) neutron scattering makes it possible to characterize
lateral correlations on the surface and interlayer boundaries. It should be noted that the active use of
the reflectometry method for investigations of ferrofluid structures at interfaces was started about a
decade ago (e.g., [142]).
The structural features of several kinds of aqueous magnetic fluids [143–146], as well as
surfactant/polymer solutions [147–149], which are used for magnetic nanoparticle stabilization in
water, were investigated in detail by SANS (Figures 12 and 13). Additionally, magnetic nanoparticles
with bio-macromolecules were successfully studied by SANS and SAXS [150,151] (Figure 14). Thus,
investigations of magnetic fluid stability at various amounts of surfactants and aggregation of
MNPs were undertaken by SAS for ferrofluids based on non-polar and polar (aqueous) carriers.
For water-based ferrofluids with sterical/charge stabilization (double-layer coating of magnetite
nanoparticles by sodium oleate (SO) or dodecylbenzene sulfonic acid (DBSA)), the fraction of micelles
of formed by non-adsorbed surfactant molecules was found by SANS (Figure 12). It was shown
that the different rate of surfactant adsorption on the particle surface depends on the surfactant
type. The aggregate reorganization and growth in ferrofluids after ‘PEGylation’ [145] were observed
(Figure 13). The SANS study was performed on mixed SO/polyethylene glycol (PEG) aqueous solutions
in order to check the influence of a polymer additive on the surfactants behavior. SANS results revealed
drastic morphological and interacting changes of micelles, due to the addition of PEG.
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Neutron reflectometry used to obtain the SLD depth profiles investigated the assembly of
magnetite nanoparticles in aqueous magnetic fluids close to a solid (silicon) surface under different
external conditions (shear, magnetic field, etc.) [153–156]. The adsorption of surfactant coated magnetic
nanoparticles from highly stable magnetic fluids on crystalline functionalized silicon was revealed
from the specular reflectivity curves (Figure 15). The detailed analysis of the polarized neutron
reflectometry data, together with SANS data, made it possible to obtain the magnetization depth profile
and dependence of the resultant magnetic structure on the applied fields, including the distribution
of NPs within the adsorption layer. Additionally, the impact of the solvent polarity, as well as bulk
structure of ferrofluids, including particle concentration and particle geometry on the structural
characteristics of the adsorption layer from magnetic fluids, was considered (Figure 15). The width
of the adsorption layer is consistent with the size of single particles, thus showing the preferable
adsorption of non-aggregated particles, in spite of the existing aggregate fraction in aqueous magnetic
fluids. In the case of PEG-modified ferrofluids, the reorganization of MNP aggregates was observed,
which correlates with the changes in the neutron reflectivity. It follows that the single adsorption layer
of individual nanoparticles on the oxidized silicon surface for the initial magnetic fluids disappears
after PEG modification. Consequently, in case of PEG modified magnetic fluid, all of the particles are
in aggregates that are not adsorbed by silicon (Figure 15).
A comprehensive comparative study by small-angle neutron and X-ray scattering (SAXS and
SANS) of water-based magnetic fluids with two different stabilization mechanisms—electrostatic (with
citric acid (CA) Figure 16) and electro-steric (with oleic acid (OA) double layer; Figure 17)–over a large
concentration range up to 30% hydrodynamic volume fraction, identified important differences on
the microscopic level for these colloidal systems, as evidenced by the scattering curves in Figures 16
and 17. The electrostatic stabilization ensured high colloidal stability up to the highest magnetization
78.20 kA/m, while the electro-steric stabilized samples already show relatively large agglomerates at
reduced volume fraction values [85].
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just buffer (D2O) at interface with sol d (Si). It could be seen that reflectivity cur es for PEG-modified
ferrofluids and j st carrier (D2O) ar very similar and indicates on the absence of any nanoscale l yer
at interface. (b) Correlation between bulk structure of ferrofl ids according to SANS and at interface
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adsorption of MNPs on solid in case of fractal branched aggregates in ferrofluids bulk. Reprinted with
permission from Reference [153].
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Light scattering based structural characterization of magnetic colloids are an affordable 
laboratory table top alternative to SANS and SAXS. Therefore, a wide spectrum of equipment is 
already available on the market to help researchers with the fast and accurate characterization of 
magnetic colloids at nano and mesoscale, both spontaneous and magnetically induced. 
Dynamic Light Scattering (DLS) uses the photon correlation spectroscopy to determine the 
colloidal particle hydrodynamic diameter from the time fluctuations of the light scattered by the 
colloid sample [157]. Static Light Scattering (SLS) uses the angle dependence of the scattered light 
intensity to determine the colloidal particle diameter via the Lorentz–Mie light scattering theory 
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4.4.2. Light Scattering
Light scattering based structural characterization of magnetic colloids are an affordable laboratory
table top alternative to SANS and SAXS. Therefore, a wide spectrum of equipment is already available
on the market to help researchers with the fast and accurate characterization of magnetic colloids at
nano and mesoscale, both spontaneous and magnetically induced.
Dynamic Light Scattering (DLS) uses the photon correlation spectroscopy to determine the
colloidal particle hydrodynamic diameter from the time fluctuations of the light scattered by the
colloid sample [157]. Static Light Scattering (SLS) uses the angle dependence of the scattered light
intensity to determine the colloidal particle diameter via the Lorentz–Mie light scattering theory [158].
The spontaneous aggregation state of the nanoparticles in the colloid can be assessed while using DLS
and SLS together with TEM and/or magnetogranulometry data.
Light scattering is also useful for the characterization of magnetically induced aggregation in
magnetic colloids (Figure 18a). An ensemble of parallel prolate objects will scatter light in the plane
perpendicular to their shape anisotropy axis, i.e., the scattering plane [158]. The polar angular
dependence of the scattered light, i.e., the scattering pattern, can be measured on a projection plane
perpendicular to the light propagation direction. 5 s interval scattering patterns from the application of
20 kA/m and 40 kA/m magnetic field, respectively, to a aqueous magnetic nanogel colloid are presented
in Figure 17a top and Figure 18a bottom [35]. The scattering patterns themselves and their time
evolution show the formation and growth of magnetically induced spindle-like (Figure 18b) aggregates
in the colloid. The stronger the magnetic field, the more intense the scattering pattern, and, thus, the
more voluminous the aggregated phase. Magnetically induced aggregation in magnetic colloids is of
primary concern for practical application due to the potential catastrophic loss of specific surface and/or
blood vessels clogging during in vivo experiments. Mesoscale aggregation in magnetic colloids leads
to the formation of magnetic field oriented spindle like clusters (Figure 18b), with thickness in the order
of microns and lengths in the order of tens to hundreds microns [35,63]. Recently, it was discovered
that large scale structuring could be induced by high frequency magnetic fields with amplitude as low
as 40 Oe, in suspensions of magnetic multicore-shell nanoparticles (MMCS) [159].
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field dependence of the weight of nanoparticles contained in the aggregates [35]. 
Figure 19 presents the magnetic field dependence of the supersaturation in three types of MMCS 
dispersions. The 40 kA/m DC field supersaturation for aqueous dispersions of 60 nm MMCS hardly 
reaches 0.1% (Figure 19a), while, for 100 nm, MMCSs reach almost 50% (Figure 19b). A 10 kA/m 
amplitude 100 kHz AC field induces almost 80% supersaturation in 250 nm MMCS dispersion (Figure 
19c). Thus, the shear magnitude of the aggregation phenomena should be a priority concern for any 
practical applications, depending on the composite size and magnetic field intensity. 
Figure 18. (a) Light scattering pat er s ls after field onset for 20 kA/m (top) and 40 kA/m
(bott m) and (b) Optical microscopy i age i lly induced spindle like aggregates (the scale
bar is 25 microns). Reprinted with per issi fr f re ce [35].
Although this large scale structuri r ed ith optical microscopy, light scattering
offers the advantage of determining the magnetic supersaturation of the coll id, i.e., the magnetic field
dependence of the weight of nanoparticles contained in the aggregates [35].
Figure 19 presents the magnetic field dependence of the supersaturation in three types of MCS
dispersions. The 40 kA/m DC field supersaturation for aqueous dispersions of 60 nm MMCS hardly
reaches 0.1% (Figure 19a), while, for 100 nm, MMCSs reach almost 50% (Figure 19b). A 10 kA/m
amplitude 100 kHz AC field induces almost 80% supersaturation in 250 nm MMCS dispersion
(Figure 19c). Thus, the shear magnitude of the aggregation phenomena should be a priority concern
for any practical applications, depending on the composite size and magnetic field intensity.Magnetochemistry 2020, 6, x FOR PEER REVIEW 22 of 36 
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Figure 19. Magnetic field dependence of supersaturation for: (a) 60 nm magnetic multicore-shell 
nanoparticles (MMCS) in DC field. Reprinted with permission from Reference [35], (b) 100 nm MMCS 
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4.5. Rheology and Magnetorheology of Aqueous Ferrofluids
In the case of aqueous bio-ferrofluids usually the multi-core particles in the 50–100 nm size range
are predominant. Additionally, while bio-ferrofluids are highly diluted, vector magnetometry and
SANS data indicate field dependent “colloidal” anisotropies that arise from the competition between
steric repulsion and magnetostatic attraction between particles, having a significant influence on the
magnetorheology of these colloids [160].
In the case of concentrated ferrofluids, achieving a high saturation magnetization value requires
the increase of physical volume fraction and, thus, a corresponding increase of the hydrodynamic
volume fraction, however to different extents, depending on the stabilization mechanism, electrostatic
or electro-steric [161]. The electrostatically stabilized ferrofluids have the advantage of reducing the
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total suspended material at constant magnetic volume fraction when compared with a surfactant
stabilized fluid [162], due to the much greater thickness of the steric stabilizing layer.
Vasilescu and colab. made an in-depth analysis on two basic types of water based magnetic fluids
(MFs), containing magnetite nanoparticles with electrostatic and with electro-steric stabilization, both
being obtained by chemical coprecipitation synthesis under atmospheric conditions [85]. The two sets
of magnetic fluid samples, one with citric acid (MF/CA) and the other with oleic acid (MF/OA) coated
magnetic nanoparticles, respectively, achieved saturation magnetization values MS = 78.20 kA/m for
the electrostatically and MS = 48.73 kA/m for the electro-sterically stabilized aqueous ferrofluids, which
are among the highest reported to date. These fluids show both similarities and important differences
in their microscopic and macroscopic properties.
The two types of ferrofluids manifest different structuring behavior, as evidenced by small angle
scattering investigations (Figures 16 and 17); therefore, significant differences are expected in their
magnetorheology, in particular concerning the magnitude of the magnetoviscous effect (expressed as
the relative field-induced change of viscosity in the presence of a magnetic field, (ηH − ηH=0)/ηH=0).
The most concentrated electro-steric stabilized (oleic acid) magnetic fluid sample (MF/OA9) shows
shear-thinning (pseudoplastic), both in zero and non-zero magnetic fields—Figure 20, due to particle
agglomerates that are progressively destroyed at increasing shear rate values. The applied field induces
the formation of new agglomerates, besides those already existing in zero field, as evidenced by the
observed magnetoviscous effect (MVE). After demagnetization, the viscosity values remain slightly
increased with respect to the initial values, which shows that the agglomerates that formed in the
applied field do not fall apart when the field is switched off (are irreversible at the characteristic
timescale of measurements).
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The electrostatic stabilized (citric acid) highest concentration magnetic fluid sample (MF/CA12) has
an approximately Newtonian behavior in zero and non-zero magnetic field—Figure 20. From viscosity
curves, the MVE is relatively reduced and almost independent of the shear rate. Furthermore, the
magnetic field induced agglomeration of particles is partly irreversible; after demagnetization, the
viscosities are somewhat higher than the initial values. Moreover, at B = 337 mT, the sample becomes
slightly pseudoplastic.
Representing MVE vs. shear rate and vs. magnetic field induction (Figure 21a,b), it was observed
that, for small shear rates, the magnetoviscous effect is considerably higher for the MF/OA9 sample.
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At shear rates γ > 102·s−1, the situation changes and the MVE is somewhat greater for the MF/CA12
sample, which indicates the existence of loosely bound agglomerates in the OA stabilized sample,
which are disrupted by increasing the shear rate. Abrupt and irreversible changes of the effective
viscosity in magnetic fields, which would reflect magnetic field induced phase separation, were not
observed. The MVE of the citric acid stabilized magnetic fluid sample is mainly determined by
the physical particle volume fraction, which is approx. two times higher than that of the oleic acid
stabilized sample.
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In good correlation with the results of small-angle scattering, the MVE values at low shear rates
were found to be more pronounced for the MF/OA9 sample than for the MF/CA12 sample, which
denotes the presence of agglomerates (the existence of correlations) already at small volume fraction
values in the case of MF/OA magnetic fluids. However, the observed viscosity increase is moderate
when compared to the more than an order of magnitude increase of the effective viscosity in the case of
bio-ferrofluids [16].
Bio-ferrofluids having multi-core particles [40,52,53,163–166] demonstrated an increasing interest
for the biomedical area during the last years. The higher particle diameter, still guaranteeing a stable
suspension, but without magnetized clumps of particles that are caused by remanence, allows for a
more effective collection of the particles by the liver. Ferrofluids with multicore particles manifest
a rather strong magnetorheological effect, despite the comparatively low concentration of magnetic
nanoparticles specific to nanomedicine applications [167,168]. As the concentration of MNPs in blood
flow is rather low, for the simulation of the rheological behavior the investigation of dilute ferrofluids
is a first step [164,168], including MVE measurements. Nowak and Odenbach developed a capillary
viscometer [167], providing a flow situation comparable to the flow in a blood vessel, and having
the range of the shear rates adapted to what is expected in the human organism due to the very low
zero field viscosity and for a realistic evaluation of MVE. The special capillary viscometer proved
to be suitable for measuring the magnetoviscous effect in bio-ferrofluids and the results show good
correlation with data measured by rotational rheometry—Figure 22.
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was very small: λ* = 0.09, and a particle interaction (and implicitly for MVE) is only expected for
values of the interaction parameter λ* > 1. Here, M0 is the spontaneous magnetization, µ0—the
vacuum permeability, kB—the Boltzmann constant, T—the temperature, d—the core diameter, and
s—the surfactant thickness.














in which µF represents the relative permeability of the fluid, µP—the particles’ relative permeability,
β—the magnetic contrast factor, and H0—the magnetic field strength. The interaction parameter
at H = 10 kA/m has the values: λMC = 1.08 for fluidMAG-D-100 nm and λMC = 20.1 for
fluidMAG-D-200 nm, which ensures a great MVE—Figure 23.
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Fig re 23. The shear rate dependence of the MVE of three ferrofluid samples at H = 30 kA/m.
The commercial fluidMAG-DX-100 nm, investigated in previous studies [167,168], has multicore
particles with hydrodyna ic diameter 100 nm and stabilized with dextran. Reprinted with permission
from Reference [164].
It can be observed from Figure 23 that MVE strongly increases with increasing hydrodynamic
diameter, which proves the strong influence of the microscopic makeup of the fluid on this effect.
The difference of approx. 20% for MVE for samples fluidMAG-DX-100 nm and fluidMAG-D-100 nm
is most likely due to different surfactants (dextran, respective starch) and to different thicknesses
of surfactant layers. In addition, MVE increases with intensifying of the magnetic field, due to
increasing magnetic interactions between the particles, according to the previously mentioned
interaction parameter λMC, favoring particle agglomeration—Figure 24—and the MVE decreases
with increasing shear rate—Figures 23 and 24—due to the rupturing of chain-like structures induced
by the magnetic field.Magnetochemistry 2020, 6, x FOR PEER REVIEW 26 of 36 
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o ak et al. [167] have comparatively investigated a dilution series starting from two
bio-ferrofluids to determine direct connections between the microscopic make-up and the actual
rheological behavior as well to establish a condition comparable with the concentration of the
fluids in blood flow during the biomedical application: fluidMAG-DX-100 nm (GmbH, Berlin,
Germany) and FF054L (provided by the research group of Prof. Alexiou, Erlangen, Germany).
Both ferrofluids are based on multi-core magnetite/maghemite particles with 100 nm mean particle
diameter. Both ferrofluids have Newtonian behavior in the absence of a magnetic field—Figure 25.
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For most biomedical applications, the ferrofluids are supposed to a dilution after injection
into the blood flow; therefore, both samples investigated in [16] were diluted with distilled water.









—when magnetoviscous effect exceeds about 300%, but, if K > 10,
the MVE is hardly detectable. For diluted ferrofluids, the shear dependency of the MVE is still
manifestly present.
5. Concluding Remarks and Theranostic Prospects
The development of various nanoparticle systems for nanomedicine is a challenging task of present
day’s material science. In this context, iron oxide nanoparticle systems are among of the most promising
nanomaterials in clinical diagnostic and therapeutic applications (theranostics); therefore, the review
was focused on efficient manufacturing procedures and manifold characterization methods of these
magneto-responsive systems. The recent progress in designed synthesis and multiple functional coating
of single- and multicore magnetic nanocomposite particles for imaging, drug delivery, hyperthermia,
or point-of-care diagnostics was thoroughly evaluated in correlation with the results of advanced
physical-chemical characterization methods, among them X-ray photoelectron spectroscopy, AC
susceptometry, small-angle neutron and X-ray scattering, neutron reflectometry, and magnetorheology,
beside the more frequently used techniques, such as high resolution transmission electron microscopy,
dynamic and static light scattering, or zeta potential measurements. The reviewed manifold physical,
chemical, and colloidal characterization is undoubtedly required in order to ensure the desired outcome
in the near future of standardized manufacturing of magnetic nanoparticle systems for nanomedicine
applications before the translation of novel laboratory creation into the viable clinical product including
safety, regulatory, and ethical requirements.
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